| |
|
|
|
|
|
|
|||
|
JA Kazmierowski, RJ Elin, HY Reynolds, WA Durbin and SM Wolff
Transplantation of normal bone marrow to mice with the Chediak-Higashi
syndrome (CHS) resulted in normal granulopoiesis and a reversal of their
increased susceptibility to challenge with intravenous Candida albicans.
These findings suggest that (1) the leukocyte defect in CHS can be reversed
by marrow transplantation and (2) the mechanism for increased
susceptibility to infection in these animals is due to a bone-
marrow-derived cellular defect. Because of similarities between murine and
human CHS, bone marrow transplantation might be considered as a mode of
therapy in selected cases of the human disease.
This article has been cited by other articles:
| ||||||||||
| Copyright © 1976 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||